Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Osanni Bio Secures $190 Million in Series B Financing Led by Patient Square Capital
Gunderson Dettmer has advised Osanni Bio. Ropes & Gray has advised Patient Square Capital. Osanni Bio, a development-stage therapeutics platform, has completed a $190 million Series...
Carbon Direct Acquires Pachama to Strengthen Digital MRV Expertise
Gunderson Dettmer has advised Pachama. Carbon Direct, a global leader in science-driven carbon management, has completed the acquisition of climate technology company Pachama. The transaction aims...
Atlas’ $155 Million Series Seed Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Atlas Data Storage in the transaction. Atlas Data Storage, Inc., a technology company building end-to-end DNA data storage,...
Edwards Lifesciences’ Acquisition of JenaValve
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented JenaValve Technology in the transaction. Involved fees earner: Heather Aune – Gunderson Dettmer Stough Villeneuve Franklin & Hachigian;...
BillionToOne’s $130 Million Series D Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented BillionToOne in the transaction. BillionToOne, a next-generation molecular diagnostics company, announced it has raised $130 million in Series...
Veradigm’s $140 Million Acquisition of ScienceIO
McDermott Will & Emery represented Veradigm Inc. in the transaction, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ScienceIO. Veradigm Inc. (NASDAQ: MDRX) (the “Company”),...
Colossal Biosciences’ $150M Series B Financing
Gunderson Dettmer represented Colossal Biosciences on the deal. Colossal Biosciences, a genetic engineering company, announced its $150 million Series B financing led by United States Innovative Technology...
BillionToOne’s Equity and Debt Financing for Next-Gen Molecular Diagnostics
Gunderson Dettmer represented BillionToOn on the deal. BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to...
BillionToOne’s $125 Million Series C Financing
Gunderson Dettmer represented BillionToOne on the deal. BillionToOne, a next-generation molecular diagnostics company, announced the $125 million Series C financing co-led by Adams Street Partners and Hummingbird...
Taboola’s $800 Million Acquisition of Connexity
JPMorgan Chase Bank, N.A. and Credit Suisse AG acted as financial advisors to Taboola. JPMorgan Chase Bank, N.A. and Credit Suisse AG are providing committed debt...
XOMA’s Acquisition of Royalty and Milestone Interest in Checkmate’s Vidutolimod from Kuros Biosciences
Paul Hastings advised Xoma Corporation on the deal. Vischer advised Kuros Biosciences AG. Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator, announced the acquisition of the royalty interest...